https://www.selleckchem.com/products/sbp-7455.html
BACKGROUND Lung adenocarcinoma (LUAD) has become the most frequent histologic type of lung cancer in the past several decades. Recent successes with immune checkpoint blockade therapy have demonstrated that the manipulation of the immune system is a very potent treatment for LUAD. This study aims to explore the role of immune-related genes in the development of LUAD and establish a signature that can predict overall survival for LUAD patients. METHODS To identify the differential expression genes (DEGs) between normal and tumor tissues
Like
Comment
Share
